| Literature DB >> 8750907 |
C Johansson1, A Stark, M Sandberg, B Ek, L Rask, J Meijer.
Abstract
The soluble epoxide hydrolase mRNA level in liver was increased eight-fold upon administration of the hypolipidemic drug and peroxisome proliferator clofibrate for 7 days to mice. The soluble epoxide hydrolase mRNA was back at control levels within 1-2 days after clofibrate withdrawal. The highest expression was in liver, intestine and kidney. Lower levels were found in heart and muscle and very low levels were found in testes, lung, brain and spleen. The mRNA levels were increased in liver, kidney and heart by clofibrate.Entities:
Mesh:
Substances:
Year: 1995 PMID: 8750907 DOI: 10.1007/s002040050250
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153